Wang, Lei
Lonard, David M.
O’Malley, Bert W.
Funding for this research was provided by:
the Susan G. Komen Foundation (PG12221410)
Prostate Cancer Foundation
the Department of Defense Breast Cancer Research Program (BC120894)
the Cancer Prevention and Research Institute of Texas (RP100348, RP101251)
National Institutes of Health (DK059820, HD076596)
Article History
Received: 12 January 2016
Accepted: 8 March 2016
First Online: 28 April 2016
Compliance with Ethical Standards
:
: LW, DML, and BWO are co-founders and hold stock in Coregon, Inc., which is developing steroid receptor coactivator stimulators for clinical use.
Free to read: This content has been made available to all.